Results
179
Companies with strong growth potential, backed by optimistic outlooks both from analysts and management.
179 companies
Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | Industry | ||
---|---|---|---|---|---|---|---|---|---|---|---|
EH | US$11.86 | -7.3% | -43.0% | US$750.6m | US$24.98 | PS34.2x | E74.3% | n/a | Capital Goods | ||
CRDO | US$25.33 | -11.4% | 54.0% | US$4.2b | US$32.17 | PS21.7x | E60.9% | n/a | Semiconductors | ||
ATAT | US$15.84 | -5.7% | -24.7% | US$2.2b | US$26.42 | PE16x | E21.9% | 0.9% | Consumer Services | ||
GCT | US$25.56 | -10.1% | 181.5% | US$1.0b | US$52.57 | PE9.9x | E24.7% | n/a | Retail | ||
TBBB | US$25.65 | -4.6% | n/a | US$2.9b | US$26.84 | PS1.2x | E94.7% | n/a | Consumer Retailing | ||
PDD | US$127.41 | -2.6% | 45.6% | US$176.9b | US$207.40 | PE15.9x | E21.6% | n/a | Retail | ||
VCTR | US$47.21 | -11.7% | 42.0% | US$3.1b | US$52.00 | PE13.9x | E32.3% | 3.1% | Diversified Financials | ||
CG | US$44.23 | -6.3% | 37.4% | US$15.9b | US$48.30 | PS7.2x | E23.6% | 3.2% | Diversified Financials | ||
SMCI | US$624.65 | -12.3% | 84.8% | US$36.6b | US$1,014.25 | PE34.9x | E39.0% | n/a | Tech | ||
DUOL | US$162.01 | -6.5% | 17.9% | US$7.0b | US$250.46 | PE153.2x | E47.9% | n/a | Consumer Services | ||
BRDG | US$7.66 | -3.9% | -37.8% | US$926.7m | US$9.88 | PB3.6x | E98.2% | 8.6% | Diversified Financials | ||
ZKH | US$2.80 | -6.7% | n/a | US$451.0m | US$15.74 | PB1x | E104.4% | n/a | Capital Goods | ||
MAX | US$16.43 | 11.4% | 83.2% | US$1.1b | US$24.67 | PS1.8x | E59.4% | n/a | Media | ||
WULF | US$3.67 | -17.0% | 39.5% | US$1.2b | US$6.84 | PS12.2x | E99.5% | n/a | Software | ||
LOOP | US$1.70 | -4.5% | -44.4% | US$80.8m | US$7.25 | PS612.2x | E79.3% | n/a | Materials | ||
EVOK | US$5.31 | -11.7% | -71.1% | US$3.8m | US$84.00 | PB1.1x | E110.6% | n/a | Pharmaceuticals & Biotech | ||
NEON | US$2.70 | -10.3% | 26.2% | US$41.5m | US$3.00 | PS9.9x | E158.0% | n/a | Tech | ||
RYAN | US$68.57 | 13.1% | 58.8% | US$17.9b | US$63.78 | PE105.2x | E51.1% | 0.6% | Insurance | ||
MDGL | US$275.36 | -3.2% | 41.6% | US$5.9b | US$365.33 | PB6.9x | E64.4% | n/a | Pharmaceuticals & Biotech | ||
ALKT | US$32.24 | -3.6% | 99.5% | US$3.2b | US$35.30 | PS10.7x | E98.5% | n/a | Software | ||
SPOT | US$330.85 | 2.8% | 129.6% | US$66.4b | US$383.37 | PE130.6x | E29.5% | n/a | Media | ||
SMSI | US$1.98 | -23.0% | -77.9% | US$21.0m | US$10.17 | PB0.5x | E80.6% | n/a | Software | ||
HOFV | US$2.35 | -19.0% | -77.4% | US$15.3m | US$8.00 | PB0.1x | E71.1% | n/a | Consumer Services | ||
XPEV | US$7.56 | -11.2% | -58.7% | US$7.1b | US$12.25 | PS1.5x | E63.2% | n/a | Automobiles |